EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mitochondrial transfer-driven immune evasion in the tumor microenvironment

Li Zhu, Yosuke Togashi iD

International Immunology · 01.10.2026 · 38 (10) · 603-609

DOI: 10.1093/intimm/dxag027 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Immunology, online erschienen am 29.05.2026. Verfasst von Li Zhu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tumor Microenvironment, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan. Hauptthemen laut MEDLINE: Mitochondria, Tumor Microenvironment, Neoplasms, Tumor Escape. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science (JSPS), Japan Agency for Medical Research and Development (AMED), Promotion of Cancer Research and Therapeutic Evolution.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The tumor microenvironment (TME) is a complex landscape where metabolic interactions significantly dictate antitumor immunity. Immune evasion in cancer is typically discussed in terms of inhibitory receptors and ligands, suppressive cytokines, defective antigen presentation, and metabolic competition. However, recent evidence reveals that intercellular mitochondrial transfer adds a new mechanism of immune evasion in the TME. The mitochondrial fitness of T cells is central to sustained effector function, memory formation, and responsiveness to immune-checkpoint blockade. Tumor cells can act as pathogenic mitochondrial donors, transferring functional or dysfunctional mitochondria to neighboring T cells via tunneling nanotubes and extracellular vesicles. This process involves a mitophagy imbalance that leads to the homoplasmic replacement of endogenous mitochondria, thereby driving T-cell senescence, impairing memory formation and long-term antitumor function, and ultimately weakening cancer immunosurveillance. Overall, mitochondrial transfer should be considered a new part of the tumor immune evasion framework. It also provides new therapeutic opportunities for improving cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitochondriaTumor MicroenvironmentNeoplasmsTumor EscapeImmune EvasionHumansAnimalsT-LymphocytesT-Cell Exhaustion

Stichwörter der Autor:innen

T-cell exhaustionimmune checkpoint blockademitochondrial transfertumor-infiltrating lymphocytes

Autor:innen und Institutionen

  • Department of Tumor Microenvironment, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan.
  • Advanced Research Field, Institute for Emerging Medical Innovation, Okayama University Hospital, Okayama 700-8558, Japan.
  • Department of Respiratory Medicine, Okayama University Hospital, Okayama 700-8558, Japan.
  • Faculty of Medicine, Kindai University, Osaka 589-8511, Japan.

ORCID-Profile: Yosuke Togashi

Förderung

  • Japan Society for the Promotion of Science (JSPS)
  • Japan Agency for Medical Research and Development (AMED)
  • Promotion of Cancer Research and Therapeutic Evolution
  • Research Program for Hepatitis

Zitieren

APA

Zhu, L., & Togashi, Y. (2026). Mitochondrial transfer-driven immune evasion in the tumor microenvironment. International Immunology, 38(10), 603-609. https://doi.org/10.1093/intimm/dxag027

Vancouver

Zhu L, Togashi Y. Mitochondrial transfer-driven immune evasion in the tumor microenvironment. International Immunology. 2026;38(10):603-609. doi:10.1093/intimm/dxag027

BibTeX
@article{Zhu2026,
  author = {Zhu, Li and Togashi, Yosuke},
  title = {Mitochondrial transfer-driven immune evasion in the tumor microenvironment},
  journal = {International Immunology},
  year = {2026},
  volume = {38},
  number = {10},
  pages = {603--609},
  doi = {10.1093/intimm/dxag027}
}
Kostenlos starten →